Literature DB >> 7942440

Morbidity and mortality rates in elderly patients undergoing percutaneous coronary transluminal angioplasty.

J Lindsay1, V M Reddy, E E Pinnow, T Little, A D Pichard.   

Abstract

Although successful dilatation of a target lesion by means of percutaneous transluminal coronary angioplasty (PTCA) can be attained as frequently in elderly as in younger patients, elderly patients have a higher risk of complications. Furthermore, cohorts of patients older than 75 years and undergoing PTCA include more women and more cases of unstable angina, factors that increase the risk of complications. Included in this analysis of 3199 PTCAs performed between January 1991 and September 1992 were 474 (14.8%) patients who were > or = 75 years old. Age was an independent risk factor for death, acute myocardial infarction, need for transfusion, and need for arterial repair after PTCA. The frequency of successful dilatation of individual lesions, emergency coronary bypass surgery, or repeated PTCA of the same lesion was not related to age. In previous studies no association has been demonstrated between age and increased risk of in-hospital reclosure. The presence of more severe coronary disease and of the greater frequency of coexisting morbid conditions makes elderly patients less able to tolerate unsuccessful or complicated PTCA.

Entities:  

Mesh:

Year:  1994        PMID: 7942440     DOI: 10.1016/0002-8703(94)90267-4

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  5 in total

1.  Macrophage-derived IL-18 and increased fibrinogen deposition are age-related inflammatory signatures of vascular remodeling.

Authors:  Luis Rodriguez-Menocal; Mohd Hafeez Faridi; Laisel Martinez; Lina A Shehadeh; Juan C Duque; Yuntao Wei; Annia Mesa; Angela Pena; Vineet Gupta; Si M Pham; Roberto I Vazquez-Padron
Journal:  Am J Physiol Heart Circ Physiol       Date:  2014-01-10       Impact factor: 4.733

2.  Quality of life of patients with chronic stable angina before and four years after coronary revascularisation compared with a normal population.

Authors:  B Brorsson; S J Bernstein; R H Brook; L Werkö
Journal:  Heart       Date:  2002-02       Impact factor: 5.994

3.  Sestrin2 prevents age-related intolerance to ischemia and reperfusion injury by modulating substrate metabolism.

Authors:  Nanhu Quan; Wanqing Sun; Lin Wang; Xu Chen; Jonathan S Bogan; Xinchun Zhou; Courtney Cates; Quan Liu; Yang Zheng; Ji Li
Journal:  FASEB J       Date:  2017-06-07       Impact factor: 5.191

4.  Impact of genetic variants on clinical outcome after percutaneous coronary intervention in elderly patients.

Authors:  Jung-Joon Cha; Jae Hyoung Park; Hyung Joon Joo; Soon Jun Hong; Tae Hoon Ahn; Byeong-Keuk Kim; WonYong Shin; Sung Gyun Ahn; JungHan Yoon; Yong Hoon Kim; Yun-Hyeong Cho; Woong Chol Kang; Weon Kim; Young-Hyo Lim; Hyeon Cheol Gwon; Woong Gil Choi; Do-Sun Lim
Journal:  Aging (Albany NY)       Date:  2021-03-12       Impact factor: 5.955

5.  Incremental age-related one-year MACCE after acute myocardial infarction in the drug-eluting stent era (from KAMIR-NIH registry).

Authors:  Dae-Won Kim; Sung-Ho Her; Ha Wook Park; Kiyuk Chang; Wook Sung Chung; Ki Bae Seung; Myung Ho Jeong; Hyo-Soo Kim; Hyeon Cheol Gwon; In Whan Seong; Kyung Kuk Hwang; Shung Chull Chae; Kwon-Bae Kim; Young Jo Kim; Kwang Soo Cha; Seok Kyu Oh; Jei Keon Chae; Ji-Hoon Jung
Journal:  J Geriatr Cardiol       Date:  2018-09-28       Impact factor: 3.327

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.